Ellen Ypma

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

Karl G. Nicholson, Anthony Colegate, Audino Podda et al. · The Lancet · 2001 · 444 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

Nicoletta Gossger, Matthew D. Snape, Ly‐Mee Yu et al. · JAMA · 2012 · 281 citations

Medicine, Infectious Diseases, Pediatrics +17

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

Timo Vesikari, Susanna Esposito, Roman Prymula et al. · The Lancet · 2013 · 274 citations

Veterinary Medicine, Immunology, Pediatrics +17

Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

Jamie Findlow, Ray Borrow, Matthew D. Snape et al. · Clinical Infectious Diseases · 2010 · 255 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life

Matthew D. Snape, Tom Dawson, Philipp Oster et al. · The Pediatric Infectious Disease Journal · 2010 · 187 citations

Veterinary Medicine, Immunology, Infectious Diseases +17